Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast in Mild ARDS
NCT04744090Phase 2Completed
- Sponsor
- Cairo University
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of roflumilast in acute respiratory distress syndrome (ARDS), sponsored by Cairo University. Started Mar 2021; status: completed.
02
Drugs
roflumilast
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04744090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04744090.